Hyperphosphatemia in Children With Chronic Kidney Disease
Hyperphosphatemia
About this trial
This is an interventional treatment trial for Hyperphosphatemia
Eligibility Criteria
Inclusion Criteria:
- Children aged from 6 to 18 years
- With end stage renal disease on regular hemodialysis,
- With hyperphosphatemia (serum phosphorus > 4.5mg/dL ).
- Both genders will be included
- Given informed concent.
Exclusion Criteria:
- - Children < 6 years,
- Severe Gastrointestinal disorder,
- Known hypersensitivity to phosphate binders,
- Inability or rejection to give informed consent,
- Normal serum phosphate level.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
calcium group
sevelamer group
will receive calcium-based phosphate binder (calcium carbonate ) 45-65 mg/kg orally divided 3 to 4 times/day for 3 months. all the following investigation will be done before and after consecutive 3 months of administration : Complete blood count Kidney function tests (serum urea and creatinine) Serum total calcium level. Serum phosphorus level. Calcium × phosphorus product. Serum parathormone level. Serum alkaline phosphatase level. Lipogram (Total cholesterol, High density lipoprotein, Low density lipoprotein and triglycerides). Echocardiography regular follow up of serum phosphate , calcium and parathyroid hormone will be done every month for dose adjustment of the drug
will receive the recommended daily dose of the Sevelamer hydrochloride phosphate binder 120-160 mg/kg orally 3 times per day for 3 months. all the following investigation will be done before and after consecutive 3 months of administration : Complete blood count Kidney function tests (serum urea and creatinine) Serum total calcium level. Serum phosphorus level. Calcium × phosphorus product. Serum parathormone level. Serum alkaline phosphatase level. Lipogram (Total cholesterol, High density lipoprotein, Low density lipoprotein and triglycerides). Echocardiography regular follow up of serum phosphate , calcium and parathyroid hormone will be done every month for dose adjustment of the drug